Coelho Rogerio Vivaldi is PRESIDENT AND CEO of Sigilon Therapeutics Inc.
Person profile
Roles
Sigilon Therapeutics
PRESIDENT AND CEO
Crinetics Pharmaceuticals
Director
Address
Waltham, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sigilon Therapeutics, Inc.
11 Aug 23
4
Sigilon Therapeutics, Inc.
24 Jul 23
4
Crinetics Pharmaceuticals, Inc.
21 Jun 23
4
Crinetics Pharmaceuticals, Inc.
9 Jun 23
4
Sigilon Therapeutics, Inc.
1 Mar 23
4
Crinetics Pharmaceuticals, Inc.
21 Jun 22
4/A
Crinetics Pharmaceuticals, Inc.
4 Apr 22
4
Sigilon Therapeutics, Inc.
22 Feb 22
4
Crinetics Pharmaceuticals, Inc.
10 Jan 22
3
Crinetics Pharmaceuticals, Inc.
10 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Aug 23 | SGTX Sigilon Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 12,169 | 0.00 | 0 |
11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.75 | 35,382 | 26.54 k | 0 |
21 Jul 23 | SGTX Sigilon Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 19.24 | 5,528 | 106.36 k | 11,963 |
21 Jul 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 19.24 | 5,528 | 106.36 k | 12,163 |
16 Jun 23 | CRNX Crinetics Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 6,000 | 0.00 | 11,000 |
16 Jun 23 | CRNX Crinetics Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 20.32 | 17,500 | 355.60 k | 17,500 |
8 Jun 23 | CRNX Crinetics Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 22.06 | 5,000 | 110.30 k | 5,000 |
28 Feb 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.09 | 460,000 | 501.40 k | 460,000 |